Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Increased oxidation of RNA despite reduced mitochondrial respiration after chronic electroconvulsive stimulation of rat brain tissue

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Acetazolamide lowers intracranial pressure and modulates the cerebrospinal fluid secretion pathway in healthy rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Serotonergic projections from the raphe nuclei to the subthalamic nucleus; a retrograde- and anterograde neuronal tracing study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Intraplantar injection of tetrahydrobiopterin induces nociception in mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Neurologiske Sygdomme

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducationpeer-review

  2. An in vivo Mouse Model to Investigate the Effect of Local Anesthetic Nanomedicines on Axonal Conduction and Excitability

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Nerve excitability in the rat forelimb: a technique to improve translational utility

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Sensation, mechanoreceptor, and nerve fiber function after nerve regeneration

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Mice deficient of myelin protein P0 are established models of demyelinating Charcot-Marie-Tooth (CMT) disease. Dysmyelination in these mice is associated with an ectopic expression of the sensory neuron specific sodium channel isoform NaV1.8 on motor axons. We reported that in P0+/-, a model of CMT1B, the membrane dysfunction could be acutely improved by a novel oral NaV1.8 blocker referred to as Compound 31 (C31, Bioorg. Med. Chem. Lett. 2010, 20, 6812; AbbVie Inc.). The aim of this study was to investigate the extent to which C31 treatment could also improve the motor axon function in P0-/-, a CMT model with a much more severe neuropathy. We found that the progressive impairment of motor performance from 1 to 4 months of age in P0-/- could be acutely reversed by C31 treatment. The effect was associated with an improvement of the amplitude of the plantar CMAP evoked by tibial nerve stimulation. The corresponding motor nerve excitability studies by "threshold tracking" showed changes after C31 consistent with attenuation of a resting membrane depolarization. Our data suggest that the depolarizing motor conduction failure in P0-/- could be acutely improved by C31. This provides proof-of-concept that treatment with oral subtype-selective NaV1.8 blockers could be used to improve the motor function in severe forms of demyelinating CMT.

Original languageEnglish
JournalNeuroscience Letters
Volume632
Pages (from-to)33-8
Number of pages6
ISSN0304-3940
DOIs
Publication statusPublished - 6 Oct 2016

    Research areas

  • Journal Article

ID: 49774674